Novartis this week became the fifth manufacturer to sue the Health Resources and Services Administration (HRSA) to implement a 340B rebate model. Novartis filed its complaint Wednesday in the US District Court for the District of Columbia.
Novartis this week became the fifth manufacturer to sue the Health Resources and Services Administration (HRSA) to implement a 340B rebate model. Novartis filed its complaint Wednesday in the US District Court for the District of Columbia.